Invesco’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History

Invesco’s Portfolio VAXX Stock Details VAXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-18,756	Closed	-$13.5K	–	4021
2024 Q1	$13.5K	Sell	18,756 -165	-0.9%	-$120	﹤0.01%	3846
2023 Q4	$16.1K	Sell	18,921 -2,840	-13%	-$2.74K	﹤0.01%	3807
2023 Q3	$29.8K	Hold	21,761	–	–	﹤0.01%	3831
2023 Q2	$54.8K	Buy	+21,761	New	+$46.1K	﹤0.01%	3808

Other funds holding VAXX

SWM

Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

CGL

Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Robinswood Financial Kirkland, Washington $349M AUM 14.9% 1-Year Est. Return

Invesco's VAXX Position: Q2 2024 in Review

Invesco sold out of Vaxxinity, Inc. Class A Common Stock (VAXX) in Q2 2024, closing a stake of 18,756 shares — an estimated $13.5K sold.

Invesco first reported a position in VAXX in Q2 2023 and held it in 4 quarters. The position peaked at $54.8K in Q2 2023. 8 funds tracked by Wall St. Rank hold VAXX as of Q2 2024.

Invesco reported no remaining Vaxxinity, Inc. Class A Common Stock position as of Q2 2024 after selling out during the quarter.
Invesco sold 18,756 Vaxxinity, Inc. Class A Common Stock shares in Q2 2024, an estimated $13.5K.
Invesco first reported a position in Vaxxinity, Inc. Class A Common Stock in Q2 2023 and held it in 4 quarters.
Invesco's Vaxxinity, Inc. Class A Common Stock position peaked at $54.8K in Q2 2023.
8 funds tracked by Wall St. Rank held Vaxxinity, Inc. Class A Common Stock as of Q2 2024.

Based on Invesco's 13F filing for Q2 2024, filed 13 Aug 2024.